BioSpace News Archive

Business

Apollo Endosurgery and American Gastroenterological Association to Establish Endoscopic Suturing Procedure Registry

Apollo Endosurgery announced today it has entered into a Registry Funding Agreement with the American Gastroenterological Association (AGA) Center for GI Innovation and Technology to develop and administer a registry to evaluate flexible endoscopic procedures enabled by the OverStitch™ Endoscopic Suturing System.

October 24, 2017
·
5 min read
Business

Biogen Throws Another $200M at Aducanumab With Amended Deal With Neurimmune

Despite the failures of late stage ALZ’s drugs developed by numerous companies, Biogen seems confident in the future of its amyloid plaque targeting aducanumab.

October 24, 2017
·
2 min read
·
Alex Keown
Business

AbbVie Plows $205M Upfront Into Alector’s Alzheimer’s Program

AbbVie announced a strategic collaboration with Alector to develop and commercialize drugs for ALZ’s disease and other neurodegenerative disorders.

October 24, 2017
·
3 min read
·
Mark Terry
Biotech Bay

NeuroPace Bags $74M to Market Epilepsy Device

NeuroPace snagged $74M in funding to expand commercialization of its device that treats epileptic seizures.

October 24, 2017
·
2 min read
·
Alex Keown
BioMidwest

3 High Potential Low Risk Biotechs Investors Should Watch Out For

When you think about it, most small biotech companies are odd investments.

October 24, 2017
·
3 min read
·
Mark Terry
Business

Vyaire Inks Huge Lease in Irvine to Expand

Vyaire Medical, a Chicago-based firm formerly known as CareFusion, is shifting its Orange County base to Irvine from Yorba Linda.

October 24, 2017
·
1 min read
Drug Development

Gilead Shows Off Mid-Stage NASH Data

Gilead released results from a Phase II clinical trial of GS-0976 for NASH.

October 24, 2017
·
2 min read
·
Mark Terry
Deals

Massachusetts Upstart scPharmaceuticals Files for $100M IPO

scPharmaceuticals filed recently with the SEC regarding its plans for an IPO.

October 24, 2017
·
2 min read
·
Mark Terry